Vertex Pharmaceuticals
VRTX
#178
Rank
A$175.96 B
Marketcap
A$686.30
Share price
0.81%
Change (1 day)
-6.65%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): A$6.93 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are A$11.72 Billion. In 2024 the company made an earning of A$0.42 Billion a decrease over its 2023 earnings that were of A$6.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$6.93 B1549.29%
2024 A$0.42 B-93.69%
2023 A$6.66 B3.19%
2022 A$6.45 B53.56%
2021 A$4.20 B-12.06%
2020 A$4.78 B118.45%
2019 A$2.18 B120.64%
2018 A$0.99 B1473.64%
2017 A$63.04 M197.6%
2016 A$21.18 M-102.97%
2015 -A$0.72 Billion-28.46%
2014 -A$1 Billion-51.5%
2013 -A$2.06 Billion-30584.68%
2012 A$6.74 M-95.47%
2011 A$0.14 B
2009 -A$0.9 Billion
2007 -A$0.63 Billion83.1%
2006 -A$0.34 Billion59.02%
2005 -A$0.22 Billion3.28%
2004 -A$0.21 Billion-38.16%
2003 -A$0.34 Billion
2000 -A$57.3 Million-20.38%
1999 -A$71.96 Million31.62%
1998 -A$54.67 Million91.05%
1997 -A$28.62 Million-36.24%
1996 -A$44.88 Million12.45%
1995 -A$39.91 Million27.4%
1994 -A$31.33 Million-1833.33%
1993 A$1.8 M-112.12%
1992 -A$14.91 Million175%
1991 -A$5.43 Million-12.2%
1990 -A$6.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
A$14.88 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.49 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.77 B 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.09 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.78 B 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-A$0.12 Billion-101.70%๐Ÿ‡บ๐Ÿ‡ธ USA